Literature DB >> 3519564

Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections.

J B Boerema, R Pauwels, J Scheepers, W Crombach.   

Abstract

One hundred and four patients with complicated urinary tract infections (prolonged severe chronic infections or with complicated postoperative conditions) were treated for ten days with pefloxacin 400 mg bid. Bacteriological eradication of the initial pathogen was achieved in 98% of the patients. After six weeks 93% of the patients were still free of the initial infecting microorganism. Clinical improvement was achieved in 77% of the patients five to seven days after cessation of treatment. The side-effects which were definitely related to pefloxacin occurred in 9% of patients and were mostly of a gastro-intestinal, a neurological, or an allergic nature. No significant biochemical or haematological adverse reactions occurred.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519564     DOI: 10.1093/jac/17.suppl_b.103

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections.

Authors:  C Timmerman; I Hoepelman; J de Hond; T Boon; L Schreinemachers; H Mensink; J Verhoef
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

2.  Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections.

Authors:  H Giamarellou; G Perdikaris; N Galanakis; G Davoulos; K Mandragos; P Sfikakis
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 3.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 4.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

5.  A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.

Authors:  X Chevalier; E Albengres; M C Voisin; J P Tillement; B Larget-Piet
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

6.  Pharmacokinetics and tissue penetration of orally administered pefloxacin.

Authors:  J M Webberley; J M Andrews; J P Ashby; A McLeod; R Wise
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

7.  Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.

Authors:  J Cardey; C Silvain; S Bouquet; J P Breux; B Becq-Giraudon; J P Fourtillan; M Beauchant
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.